GC36254
HPGDS inhibitor 2
Also known as 7-(difluoromethoxy)-N-[4-(2-hydroxypropan-2-yl)cyclohexyl]quinoline-3-carboxamide
HPGDS inhibitor 2 is a highly potent and selective hematopoietic prostaglandin D synthase (H-PGDS) inhibitor with an IC50 of 9·9 nM
ChemicalCAS2101626-26-8MW378.41FormulaC20H24F2N2O3
- CAS number
- 2101626-26-8
- Molecular weight
- 378.41
- Formula
- C20H24F2N2O3
- Solubility
- DMSO： ≥ 150 mg/mL (396·40 mM)
- InChIKey
- YRWMWDLEUYLURJ-UHFFFAOYSA-N
- Catalogue number
- GC36254
- Brand
- GLPBIO
Computed properties PubChem CID 129247606 · XLogP 3.8 · TPSA 71.5 Ų · H-bond donors 2
- XLogP
- 3.8
- TPSA
- 71.5 Ų
- H-bond donors
- 2
- H-bond acceptors
- 6
- Rotatable bonds
- 5
- Heavy atoms
- 27
SMILES CC(C)(C1CCC(CC1)NC(=O)C2=CN=C3C=C(C=CC3=C2)OC(F)F)O
Computed descriptors from PubChem (CID 129247606), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il